Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.

Chronic obstructive pulmonary disease, or COPD, not only leads to breathing difficulties but also affects the lungs, heart ...

With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

China: A recent multicenter randomized controlled trial has highlighted the potential benefits of acupuncture as a ...

Many people with COPD have other conditions like diabetes or high cholesterol, too. Managing several conditions can be ...

The worldwide increase in both COPD and diabetes cases underscores the importance of these findings. With projections indicating significant growth in affected populations, identifying treatments ...

The CRYSTAL trial is the first large-scale study exploring the effects of directly switching symptomatic, non-frequently exacerbating patients with moderate COPD from their current treatments.

If you’ve received a COPD diagnosis, your doctor can provide you with more accurate information about your outlook based on your individual circumstances. Advances in treatments are also helping ...

belief that Ohtuvayre's bronchodilator and non-steroidal anti-inflammatory activity can re-define the COPD treatment paradigm." The encouraging sales figures come at a time when treatment options ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...